OXITRAN Trademark Information
Santhera Pharmaceuticals (Schweiz) AG
Active chemical ingredients for use in the manufacture of small molecule pharmaceuticals for treating neuromuscular and ophthalmological diseases; reagents for scientific and medical research for use in the research of small molecule pharmaceuticals and research of the treatment of neuromuscular and ophthalmological diseases; all of the foregoing excluding cleaning agents for use in laboratories and industries
Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of neuromuscular and ophthalmological diseases; Pharmaceutical preparations for the treatment of central nervous system-related conditions, neurological and muscular diseases, neuro-muscular diseases, muscular dystrophies, ataxias, amyotrophia, atrophy, ophthalmological diseases, muscle wasting, cardiomyopathies, optic nerve degradation, neurological indica...
Medical research; scientific research; medical and scientific research, namely, conducting clinical trials for others; computer programming for others for medical and science research purposes; scientific research for testing cell cultures and developing cellular test systems for evaluating new drugs and antibodies; developing test systems for detecting pharmacologically active compounds; genetic animal model testing and scientific research fo...
Perfect for these industries
This is a brand page for the OXITRAN trademark by Santhera Pharmaceuticals (Schweiz) AG
in Liestal, , 4410.
Write a review about a product or service associated with this OXITRAN trademark.
Or, contact the owner Santhera Pharmaceuticals (Schweiz) AG of the OXITRAN trademark by filing a request to communicate with
the Legal Correspondent for licensing, use, and/or questions related to the OXITRAN trademark.
On Thursday, November 17, 2016, status on the OXITRAN trademark changed to APPROVED FOR PUBLICATION.
On Tuesday, July 05, 2016, a U.S. federal trademark registration was filed for
Santhera Pharmaceuticals (Schweiz) AG, Liestal 4410.
The USPTO has given the OXITRAN
trademark serial number of 87093137.
The current federal status of this trademark filing is APPROVED FOR PUBLICATION.
The correspondent listed for OXITRAN is
MARIA A. SCUNGIO of
LOCKE LORD LLP, CHURCH STREET STATION; P.O. BOX 1470, NEW YORK, NY 10008-1470
The OXITRAN trademark is filed in the category of
Computer & Software Services & Scientific Services
The description provided to the USPTO for OXITRAN
is Active chemical ingredients for use in the manufacture of small molecule pharmaceuticals for treating neuromuscular and ophthalmological diseases; reagents for scientific and medical research for use in the research of small molecule pharmaceuticals and research of the treatment of neuromuscular and ophthalmological diseases; all of the foregoing excluding cleaning agents for use in laboratories and industries.
Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.
Trademarkia is the largest search engine for U.S. trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the LegalForce/Trademarkia network! You can register your trademark in 170+ countries in the world through LegalForce Network.
LegalForce Network can help you incorporate a business around your OXITRAN trademark in less than 5 minutes. Trademarkia makes the process easy and convenient, so start now!
Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.
Trademark Document Retrieval >>